Using ST2 in Cardiovascular Patients: A Review

References

• Weinberg EO , ShimpoM, HurwitzS, TominagaS, RouleauJL, LeeRT . Identification of serum soluble ST2 receptor as a novel heart failure biomarker . Circulation107 ( 5 ), 721 – 726 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Bayes-Genis A , Pascual-FigalD, JanuzziJLet al. Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure . Rev. Esp. Cardiol.63 ( 10 ), 1171 – 1178 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ky B , FrenchB, MccloskeyKet al. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure . Circ. Heart Fail.4 ( 2 ), 180 – 187 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bayes-Genis A , De AntonioM, GalanAet al. Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure . Eur. J. Heart Fail.14 ( 1 ), 32 – 38 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Broch K , UelandT, NymoSHet al. Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology . Eur. J. Heart Fail.14 ( 3 ), 268 – 277 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lupon J , De AntonioM, GalanAet al. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment . Mayo Clin. Proc.88 ( 3 ), 234 – 243 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gaggin HK , MotiwalaS, BhardwajA, ParksKA, JanuzziJLJr . Soluble concentrations of the interleukin receptor family member ST2 and beta-blocker therapy in chronic heart failure . Circ. Heart Fail.6 ( 6 ), 1206 – 1213 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Felker GM , FiuzatM, ThompsonVet al. Soluble ST2 in ambulatory patients with heart failure: association with functional capacity and long-term outcomes . Circ. Heart Fail.6 ( 6 ), 1172 – 1179 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gaggin HK , SzymonifkaJ, BhardwajAet al. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure . J. Am. Coll. Cardiol. Hear Fail.2 ( 1 ) 65 – 72 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Boisot S , BeedeJ, IsaksonSet al. Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure . J. Card. Fail.14 ( 9 ), 732 – 738 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Pascual-Figal DA , Manzano-FernandezS, BoronatMet al. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure . Eur. J. Heart Fail.13 ( 7 ), 718 – 725 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Manzano-Fernandez S , JanuzziJL, Pastor-PerezFJet al. Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure . Cardiology122 ( 3 ), 158 – 166 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Januzzi JL Jr , PeacockWF, MaiselASet al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study . J. Am. Coll. Cardiol.50 ( 7 ), 607 – 613 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Mueller T , DieplingerB, GegenhuberA, PoelzW, PacherR, HaltmayerM . Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure . Clin. Chem.54 ( 4 ), 752 – 756 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Rehman SU , MuellerT, JanuzziJLJr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure . J. Am. Coll. Cardiol.52 ( 18 ), 1458 – 1465 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Dieplinger B , GegenhuberA, KaarG, PoelzW, HaltmayerM, MuellerT . Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department . Clin. Biochem.43 ( 9 ), 714 – 719 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Socrates T , DefilippiC, ReichlinTet al. Interleukin family member ST2 and mortality in acute dyspnoea . J. Intern. Med.268 ( 5 ), 493 – 500 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Shah KB , KopWJ, ChristensonRHet al. Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction . Clin. Chem.57 ( 6 ), 874 – 882 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Breidthardt T , BalmelliC, TwerenboldRet al. Heart failure therapy-induced early ST2 changes may offer long-term therapy guidance . J. Card. Fail.19 ( 12 ), 821 – 828 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Eggers KM , ArmstrongPW, CaliffRMet al. ST2 and mortality in non-ST-segment elevation acute coronary syndrome . Am. Heart J.159 ( 5 ), 788 – 794 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Dhillon OS , NarayanHK, QuinnPA, SquireIB, DaviesJE, NgLL . Interleukin 33 and ST2 in non-ST-elevation myocardial infarction. comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP . Am. Heart J.161 ( 6 ), 1163 – 1170 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kohli P , BonacaMP, KakkarRet al. Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial . Clin. Chem.58 ( 1 ), 257 – 266 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Shimpo M , MorrowDA, WeinbergEOet al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction . Circulation109 ( 18 ), 2186 – 2190 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Sabatine MS , MorrowDA, HigginsLJet al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction . Circulation117 ( 15 ), 1936 – 1944 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Weir RA , MillerAM, MurphyGEet al. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction . J. Am. Coll. Cardiol.55 ( 3 ), 243 – 250 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Dhillon OS , NarayanHK, KhanSQet al. Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers? Int. J. Cardiol. 167 ( 5 ), 2182 – 2188 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Daniels LB , CloptonP, IqbalNet al. Association of ST2 levels with cardiac structure and function and mortality in outpatients . Am. Heart J.160 ( 4 ), 721 – 728 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wang TJ , WollertKC, LarsonMGet al. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study . Circulation126 ( 13 ), 1596 – 1604 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Dieplinger B , EggerM, KoehlerWet al. Prognostic value of soluble ST2 in an unselected cohort ofpatients admitted to an intensive care unit – The Linz Intensive Care Unit (LICU) study . Clin. Chim. Acta413 ( 5–6 ), 587 – 593 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Yanagisawa K , TsukamotoT, TakagiT, TominagaS . Murine ST2 gene is a member of the primary response gene family induced by growth factors . FEBS Lett.302 ( 1 ), 51 – 53 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Coyle AJ , LloydC, TianJet al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses . J. Exp. Med.190 ( 7 ), 895 – 902 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Iwahana H , YanagisawaK, Ito-KosakaAet al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells . Eur. J. Biochem.264 ( 2 ), 397 – 406 ( 1999 ).
   PubMedGoogle Scholar
• Weinberg EO , ShimpoM, De KeulenaerGWet al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction . Circulation106 ( 23 ), 2961 – 2966 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Schmitz J , OwyangA, OldhamEet al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines . Immunity23 ( 5 ), 479 – 490 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Sanada S , HakunoD, HigginsLJet al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system . J. Clin. Invest.117 ( 6 ), 1538 – 1549 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Mueller T , ZimmermannM, DieplingerB, AnkersmitHJ, HaltmayerM . Comparison of plasma concentrations of soluble ST2 measured by three different commercially available assays: the MBL ST2 assay, the Presage ST2 assay, and the R&D ST2 assay . Clin. Chim. Acta413 ( 19–20 ), 1493 – 1494 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Dieplinger B , JanuzziJLJr, SteinmairMet al. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma – the Presage ST2 assay . Clin. Chim. Acta409 ( 1–2 ), 33 – 40 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Coglianese EE , LarsonMG, VasanRSet al. Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study . Clin. Chem.58 ( 12 ), 1673 – 1681 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Dieplinger B , EggerM, PoelzW, HaltmayerM, MuellerT . Long-term stability of soluble ST2 in frozen plasma samples . Clin. Biochem.43 ( 13–14 ), 1169 – 1170 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Bayes-Genis A , ZamoraE, De AntonioMet al. Soluble ST2 serum concentration and renal function in heart failure . J. Card. Fail.19 ( 11 ), 768 – 775 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Dieplinger B , EggerM, PoelzWet al. Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females . Clin. Chem. Lab. Med.49 ( 9 ), 1515 – 1518 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Shah RV , Chen-TournouxAA, PicardMHet al. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea . Circ. Heart Fail.2 ( 4 ), 311 – 319 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• US FDA . Review memorandum for presage ST2 assay ( 2014 ). www.accessdata.fda.gov/cdrh_docs/reviews/K111452.pdf
   Google Scholar
• Wu AH , WiansF, JaffeA . Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results . Am. Heart J.165 ( 6 ), 995 – 999 ( 2013 )
   PubMed Web of Science ®Google Scholar
• Anand IS , RectorTS, KuskowskiMet al. Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial . Circ. Heart Fail.7 ( 3 ), 418 – 426 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zilinski JL , ShahRV, GagginHK, GantzerML, WangTJ, JanuzziJLJr . Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy . Crit. Care16 ( 4 ), R135 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bajwa EK , VolkJA, ChristianiDCet al. Prognostic and diagnostic value of plasma soluble suppression of tumorigenicity-2 concentrations in acute respiratory distress syndrome . Crit. Care Med.41 ( 11 ), 2521 – 2531 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yancy CW , JessupM, BozkurtBet al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines . J. Am. Coll. Cardiol.62 ( 16 ), e147 – e239 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Januzzi JL Jr , RehmanS, MuellerT, Van KimmenadeRR, Lloyd-JonesDM . Importance of biomarkers for long-term mortality prediction in acutely dyspneic patients . Clin. Chem.56 ( 12 ), 1814 – 1821 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Rehman SU , JanuzziJLJr . Natriuretic peptide testing in clinical medicine . Cardiol. Rev.16 ( 5 ), 240 – 249 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Pascual-Figal DA , Ordonez-LlanosJ, TornelPLet al. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction . J. Am. Coll. Cardiol.54 ( 23 ), 2174 – 2179 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ky B , FrenchB, LevyWCet al. Multiple biomarkers for risk prediction in chronic heart failure . Circ. Heart Fail.5 ( 2 ), 183 – 190 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Bayés-Genís A , LupónJ. Calculations. BCN Bio-HF Calculator ( 2013 ). www.bcnbiohfcalculator.org
   Google Scholar
• Lupon J , De AntonioM, VilaJet al. Development of a novel heart failure risk tool: the Barcelona bio-heart failure risk calculator (BCN bio-HF calculator) . PLoS ONE9 ( 1 ), e85466 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Juurlink DN , MamdaniMM, LeeDSet al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study . N. Engl. J. Med.351 ( 6 ), 543 – 551 ( 2004 ).
   PubMed Web of Science ®Google Scholar